Serum miR-21 May Be a Potential Diagnostic Biomarker for Diabetic Nephropathy

Experimental and Clinical Endocrinology and Diabetes - Germany
doi 10.1055/s-0035-1565095
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Georg Thieme Verlag KG

Related search

Serum miR‑22 May Be a Biomarker for Papillary Thyroid Cancer

Oncology Letters
Cancer ResearchOncology
2019English

Serum miR-26a as a Diagnostic and Prognostic Biomarker in Cholangiocarcinoma

Oncotarget
Oncology
2015English

Circulating miR-107 Could Be a Potential Biomarker for Pancreatic Ductal Adenocarcinoma

HPB
HepatologyGastroenterology
2018English

miR‑133b Is a Potential Diagnostic Biomarker for Alzheimer's Disease and Has a Neuroprotective Role

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2019English

Prediction of Diabetic Nephropathy: The Need for a Sweet Biomarker

Journal of Nephropathology
Nephrology
2013English

MiR-339-5p Inhibits Breast Cancer Cell Migration and Invasion in Vitro and May Be a Potential Biomarker for Breast Cancer Prognosis

BMC Cancer
Cancer ResearchOncologyGenetics
2010English

Combination of Three miRNA (miR-141, miR-21, and miR-375) as Potential Diagnostic Tool for Prostate Cancer Recognition

International Urology and Nephrology
UrologyNephrology
2018English

ERRATUM: Acknowledgments Correction. Cell-Free miR-27a, a Potential Diagnostic and Prognostic Biomarker for Gastric Cancer

Genomics and Informatics
EvolutionEcologyGeneticsSystematicsHealth InformaticsBehavior
2015English

KPNA2 Is a Potential Diagnostic Serum Biomarker for Epithelial Ovarian Cancer and Correlates With Poor Prognosis

Tumor Biology
MedicineCancer Research
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy